Add to watchlist
€3.44
Last updated:07/26/2021
04K: F
Knight Therapeutics Inc

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada and internationally. It offers Bijuva for the treatment of moderate to seve… Show more

P/E ratio
13.98x
vs. 263.16x forward

Price is 13.98x times more than EPS €0.246 which eaquals €3.44

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2018
2019
2020
2021
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company profile
CEO
Mr. Jonathan Ross Goodman B.A., L.L.B., M.B.A., BA, LLB, MBA
Market capitalization
Small (0.43B)